Market Snapshot

Dow inches higher but broader market wobbles as jobless claims carve out fresh COVID low

Angela Weiss/AFP/Getty Images

Referenced Symbols

The Dow Jones Industrial Average looked set to rise slightly Thursday but the broader market looked shaky after a report on weekly jobless benefit claims hit the lowest level in the COVID era, ahead of the nonfarm payrolls report for April due on Friday.

How are stock benchmarks performing?

On Wednesday, the Dow DJIA, +0.29% rose 97.31 points to close at a record 34,230.34, a gain of 0.3%, marking its 22 record closing high of 2021. The S&P 500 SPX, +0.07% added 2.93 points, or 0.1%, finishing at 4,167.59, while the Nasdaq Composite Index COMP, -0.37% fell 51.08 points, or 0.4%, to end at 13,582.42, a fourth day of losses and its longest losing streak since the five-day stretch booked on Oct. 19.

What’s driving the market?

Initial unemployment claims in the U.S. fell to 498,000 for first time in pandemic era, pointing to an improving labor market but also raising questions for some investors about the pace of improvement and the specter of rapidly rising inflation.

The weekly claims are better than the previous week’s total of 590,000, and come in better than Dow Jones estimate for claims of 527,000.

U.S. state continuing jobless claims rose 37,000 to 3.69 million and total U.S. continuing jobless claims dropped 404,509 to 16.2 million as of April 17.

Stocks have been buttressed by hope that the Federal Reserve will remain accommodative even as the U.S. and the world attempts to stage a recovery from the worst pandemic in a century.

During a CNBC interview on Wednesday Fed Vice Chairman Richard Clarida said that it is still not time to consider pulling back measures put in place by the central bank that have helped to damp the worst of the economic effects from the deadly pathogen.

“We’re still a long way from our goals, and in our new framework, we want to see actual progress and not just forecast progress,” Clarida said.

Clarida’s remarks came amid a flurry of similarly dovish comments from Fed members, aiming perhaps to dull the impact of remarks made by Treasury Secretary Janet Yellen that were seen as hawkish on Monday.

“Following Yellen’s comments about raising rates to prevent overheating, a cornucopia of Fed speakers…have swung behind the Fed’s policy stance to keep risk assets well supported,” wrote Neil Wilson, chief market analyst at Markets.com, in a note.

Talk of dialing back accommodative monetary policy in the U.S. come as the Bank of England on Thursday voted 8-1 that the pace of continuing government bond purchases can be “slowed somewhat.”

A strengthening economic backdrop and effective vaccine rollouts in the U.S. have been the main focus for bullish investors.

Equity trading, however, has been unsteady even as corporate results have beaten expectations at a historically strong pace.

In aggregate companies are reporting earnings 22.9% above expectations, which is well above the long-term average going back to 1994 of 3.6% and an average of 15.2% for the prior four quarters, according to data from I/B/E/S data from Refinitiv.

Of the 376 companies in the S&P 500 that have reported earnings to date in the first quarter of 2021, 86.7% reported above analyst expectations, which represents the highest outperformance on record.

Analysts say that investors are still struggling to find reasons to push stocks to further gains, while a fitful rotation has driven investors momentarily out of highflying technology-related stocks and into industrials, banks and energy, which had been the worst performers during the height of the pandemic-induced selling last year and are expected to perform better as economies reopen. The tech-heavy Nasdaq Composite logged its fourth straight decline on Wednesday, marking its longest losing skid since October.

Notably, a popular exchange-traded fund run by Cathie Wood, ARK Innovation ETF ARKK, -1.54%, is trading 30% below its high struck earlier this year, and off 10% in the year to date after being a 2020 highflier.  

Many market participants remain acutely attuned to the threat of a sharp and sustained rise in inflation that could prompt the Fed to move more quickly to unwind easy-money programs, despite comments from Clarida and others.

Meanwhile, vaccine makers Pfizer PFE, +0.05%,  BioNTech BNTX, -3.45%  and Moderna MRNA, -6.19% were in focus, following the announcement from U.S. Trade Representative Katherine Tai that the U.S. supports the waiver of intellectual-property protections on COVID-19 vaccines.

Another wave of Fed speakers is on deck for Thursday, with New York Fed President John Williams opening and closing remarks at a conference on employee as stakeholder at 9 a.m. Eastern,

Afterward, Dallas Fed President Rob Kaplan speaks at the Hyman Minsky conference at Bard College at 10 a.m., Boston Fed President Eric Rosengren talks to the Boston College Carroll School of Management at 11 a.m.

Cleveland Fed President Loretta Mester will deliver a speech to the University of California at Santa Barbara at 1 p.m.

In other U.S. economic reports, U.S. productivity rose at 5.4% annual rate in first quarter, while unit labor costs were down at a 0.3% rate over the same period.

Which companies are in focus?

Read Next

Read Next

Barron's: Dogecoin Started as a Joke. Now It’s Too Important to Laugh Off.

The cryptocurrency has a big following online. And that matters because large online communities can form the basis of new markets.

More On MarketWatch

About the Author